PROTHYMOSIN ALPHA-1 EFFECTS IN-VITRO ON CHEMOTAXIS, CYTOTOXICITY AND OXIDATIVE RESPONSE OF NEUTROPHILS FROM MELANOMA, COLORECTAL AND BREAST-TUMOR PATIENTS
H. Heidecke et al., PROTHYMOSIN ALPHA-1 EFFECTS IN-VITRO ON CHEMOTAXIS, CYTOTOXICITY AND OXIDATIVE RESPONSE OF NEUTROPHILS FROM MELANOMA, COLORECTAL AND BREAST-TUMOR PATIENTS, International journal of immunopharmacology, 19(8), 1997, pp. 413-420
Immunoregulatory effects of thymic peptides on functions of polymorpho
nuclear leukocytes (PMNs) are poorly investigated. We studied the effe
cts of prothymosin alpha 1 (Pro alpha 1) on PMNs from patients with co
lorectal tumors, breast tumors and melanoma (total n = 37) in comparis
on with healthy donors (n = 18), with respect to chemotaxis, cytotoxic
ity against HCT-116 colon tumor cells, oxidative response (chemilumine
scence reaction) as well as expression of surface marker molecules. We
found that Pro ctl was equally effective in stimulating the chemotact
ic activity of PMNs from tumor patients and healthy donors (43% increa
se). PMNs from tumor patients, especially with breast tumor, showed a
significant enhancement of cytotoxicity against the tumor target cells
in comparison with healthy donors. With respect to the PMNs cytotoxic
ity, only about 50% of the colorectal tumor patients and healthy donor
s responded to Pro al and FMLP. As to the oxidative response of PMNs,
elevated levels were found only among colorectal tumor patients. Pro a
lpha 1 significantly increased the oxidative response in breast and co
lorectal tumor patients by 55% and 25%, respectively. Pro alpha 1 decr
eased the expression of CD16 on PMNs of healthy donors, but not that o
f CD11a, CD11b, CD11c, CD13, CD14, CD15 and CD32. Therefore, we sugges
t, that Pro alpha 1 may improve some PMN functions of tumor patients,
associated with the proposed role in host-tumor interaction. (C) 1998
International Society for Immunopharmacology.